Allele-specific vaccine efficacy against <i>P. falciparum</i> malaria, intention-to-treat cohort.
- Matthew B. Laurens (141715)
- Mahamadou A. Thera (35284)
- Drissa Coulibaly (69544)
- Amed Ouattara (22542)
- Abdoulaye K. Kone (83853)
- Ando B. Guindo (83854)
- Karim Traore (83855)
- Idrissa Traore (253650)
- Bourema Kouriba (253644)
- Dapa A. Diallo (35287)
- Issa Diarra (83857)
- Modibo Daou (83859)
- Amagana Dolo (35286)
- Youssouf Tolo (486184)
- Mahamadou S. Sissoko (83856)
- Amadou Niangaly (83858)
- Mady Sissoko (35282)
- Shannon Takala-Harrison (486185)
- Kirsten E. Lyke (83870)
- Yukun Wu (424101)
- William C. Blackwelder (340495)
- Olivier Godeaux (253654)
- Johan Vekemans (202023)
- Marie-Claude Dubois (83866)
- W. Ripley Ballou (18039)
- Joe Cohen (18037)
- Tina Dube (253667)
- Lorraine Soisson (69549)
- Carter L. Diggs (83864)
- Brent House (201925)
- Jason W. Bennett (282156)
- David E. Lanar (83862)
- Sheetij Dutta (83863)
- D. Gray Heppner (69547)
- Christopher V. Plowe (83871)
- Ogobara K. Doumbo (67163)
Publication date
November 2013
DOIAbstract
<p>PYAR, Person Years At Risk. CI, confidence interval. ND, not done.</p>*<p>Efficacy was calculated as 1– hazard ratio obtained using Cox proportional hazards modeling.</p>†<p>Rate of malaria episodes per person-year at risk.</p>‡<p>Efficacy was calculated as 1– risk ratio obtained using Poisson regression.</p
Add to ORKG